AC Immune S.A.ACIUNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-12.9%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-12.9%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 23.81% |
| Q2 2025 | -10.53% |
| Q1 2025 | -35.71% |
| Q4 2024 | -333.33% |
| Q3 2024 | 126.09% |
| Q2 2024 | -27.78% |
| Q1 2024 | -219.15% |
| Q4 2023 | 68.67% |
| Q3 2023 | 10.00% |
| Q2 2023 | 4.76% |
| Q1 2023 | 4.55% |
| Q4 2022 | -37.50% |
| Q3 2022 | 36.00% |
| Q2 2022 | -4.17% |
| Q1 2022 | 11.11% |
| Q4 2021 | -22.73% |
| Q3 2021 | 15.38% |
| Q2 2021 | -13.04% |
| Q1 2021 | 14.81% |
| Q4 2020 | -3.85% |
| Q3 2020 | -18.18% |
| Q2 2020 | -100.00% |
| Q1 2020 | 59.26% |
| Q4 2019 | -208.00% |
| Q3 2019 | 204.17% |
| Q2 2019 | -125.53% |
| Q1 2019 | 527.27% |
| Q4 2018 | -4.76% |
| Q3 2018 | -10.53% |
| Q2 2018 | 5.00% |
| Q1 2018 | -373.97% |
| Q4 2017 | 148.67% |
| Q3 2017 | 31.82% |
| Q2 2017 | -29.41% |
| Q1 2017 | -101.18% |
| Q4 2016 | 53.06% |
| Q3 2016 | -178.26% |
| Q2 2016 | 309.09% |
| Q1 2016 | -10.00% |
| Q4 2015 | -127.78% |